ArticleJournal for immunotherapy of cancer2025

Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors.

Koichi Jinushi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.